CEB-01 by Cebiotex for Soft Tissue Sarcoma: Likelihood of Approval

CEB-01 is under clinical development by Cebiotex and currently in Phase I for Soft Tissue Sarcoma.

The top 100 venture players in biopharma today. Who’s in? What’s out?

2023 marks one of those years in life sciences when venture capital spent a lot of time looking for ways to preserve cash runways and

February 22, 2024

Dobbs decision leaving broad imprint on reproductive medicine

NEW ORLEANS — The annual meeting of the American Society of Reproductive Medicine is usually a buoyant, shiny parade of new science, fresh technology products,

October 20, 2023

Akeso initiates Phase III trials for ivonescimab in non-small cell lung cancer – Pharmaceutical Technology

Ivonescimab has been approved for marketing in China by the National Medical Products Administration (NMPA). Image Credit: didesign021 / Shutterstock. Akeso has five pivotal Phase

August 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.